Institution

Stifel Financial Research

Finvaulta tracks 5 research reports from Stifel, updated through September 25, 2026. Latest: The Other Isotope: Comecer's Nuclear Medicine Core Inside ATS.

Stifel research covering equities, commodities, and macro, from Stifel. Finvaulta indexes each report with a summary, key figures and its original publication date.

Finvaulta is an independent research collection and is not affiliated with Stifel; views and forecasts belong to the named report issuers.

Latest research

The Other Isotope: Comecer's Nuclear Medicine Core Inside ATS

Stifel·Sep 25, 2026

Stifel reiterates a Buy rating and C$44.00 target price on ATS Corporation, highlighting that temporary revenue headwinds in EV and GLP-1 overshadow the rapid expansion of its Comecer nuclear medicine division. Comecer holds a 60–65% market share in mission-critical radiopharmaceutical equipment and anchors a high-growth ~C$0.5B backlog.

Initiating Coverage with a Buy: Set to Get the W

Stifel·Sep 24, 2026

Stifel initiates coverage on Almonty Industries (NASDAQ: ALM) with a Buy rating and a $25 price target. The firm views Almonty as uniquely positioned to capitalize on structurally higher tungsten prices resulting from Chinese export curbs, driven by expanding production across its South Korean and European mines.

Attractive Entry Point for U

Stifel·Aug 26, 2026

Stifel initiates coverage on four uranium sector names, viewing current equity pullbacks as an attractive entry point supported by structural supply deficits and accelerating global nuclear demand. Preferred initiations are Paladin Energy (Buy, PT A$15.40), Bannerman Energy (Buy, PT A$5.30), and Yellow Cake (Buy, PT 725p), while initiating Deep Yellow at Sell (PT A$1.45) on full valuation.

Space Exploration Technologies Corp. Initiation of Coverage

Stifel·Jul 7, 2026

Stifel initiates coverage on SpaceX (SPCX) with a Buy rating and $190 target price. The investment thesis centers on SpaceX's dominant launch-cost moat, Starlink's massive earnings potential, and early-stage AI infrastructure optionality.

Europe Research Pack

Stifel·May 20, 2026

A comprehensive summary of European equity research covering FY26 results and trading updates across real estate, industrials, and healthcare sectors. Key themes include large-scale share buybacks and the impact of sustained high interest rates on valuations.